The Joint Pharmaceutical Analysis Group of the UU裸聊直播 of Chemistry (JPAG) and the Chromatographic Society (ChromSoc) are pleased to announce another one-day meeting in the series: 鈥淔rom cradle to grave: The Chromatographic (Analytical) method life cycle鈥�.
There will be a full and exciting programme purposefully designed to facilitate access for delegates, speakers and exhibitors to a wide range of scientists, many of whom are leaders in their fields. The meeting seeks to provide a clear insight into successful strategies in critical areas including the new and upcoming ICH Q14, USP <1220> and ICH Q2 guideline updates. It is intended to cover all stages of the method life cycle from development, through validation and transfer to continuous performance monitoring.
Focussing on analytical life cycle management within the pharmaceutical industry, latest regulatory expectations including AQbD and permitted chromatographic method changes according to the main pharmacopoeias, these knowledge sharing presentations will be delivered by highly regarded and experienced speakers across industry and regulators. A high calibre and well rounded meeting is planned with the inclusion of a fully integrated exhibition and vendor presentation programme. Ultimately, the meeting will provide unique attendee networking opportunities and a means of sharing real experiences with other professionals.
JPAG and ChromSoc are open to proposals for poster presentations to complement the currently drafted programme.
Both JPAG and ChromSoc student bursaries are available for this event.
SPEAKERS:
Alexander Blanazs - AstraZeneca
Wayne Callar - Pfizer
Brooks Ligon - AstraZeneca
Nathanael Page - Resolian
Dr Helen Poole - Avantor Sciences
There will be a full and exciting programme purposefully designed to facilitate access for delegates, speakers and exhibitors to a wide range of scientists, many of whom are leaders in their fields. The meeting seeks to provide a clear insight into successful strategies in critical areas including the new and upcoming ICH Q14, USP <1220> and ICH Q2 guideline updates. It is intended to cover all stages of the method life cycle from development, through validation and transfer to continuous performance monitoring.
Focussing on analytical life cycle management within the pharmaceutical industry, latest regulatory expectations including AQbD and permitted chromatographic method changes according to the main pharmacopoeias, these knowledge sharing presentations will be delivered by highly regarded and experienced speakers across industry and regulators. A high calibre and well rounded meeting is planned with the inclusion of a fully integrated exhibition and vendor presentation programme. Ultimately, the meeting will provide unique attendee networking opportunities and a means of sharing real experiences with other professionals.
JPAG and ChromSoc are open to proposals for poster presentations to complement the currently drafted programme.
Both JPAG and ChromSoc student bursaries are available for this event.
SPEAKERS:
Alexander Blanazs - AstraZeneca
Wayne Callar - Pfizer
Brooks Ligon - AstraZeneca
Nathanael Page - Resolian
Dr Helen Poole - Avantor Sciences
